← All stocks

Editas Medicine, Inc.

EDIT Scheduled selling only

CIK 0001650664 #3159 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$106.73K

$106.73K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 14 sales

Net

−$106.73K

$0.00 against sales at will

By person

5 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

O'Neill Gilmore Neil

CEO

—

$80.06K (4) scheduled

−$80.06K

243,189

0.1583%

$738.61K

−22.5%

Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

—

$20.33K (5) scheduled

−$20.33K

61,660

0.0401%

$187.27K

−21.9%

Parison Amy

SVP, Chief Financial Officer

—

$6.33K (5) scheduled

−$6.33K

13,839

0.0090%

$42.03K

−22.9%

Mei Baisong

EVP, CHIEF MEDICAL OFFICER

—

133,354

0.0868%

$405.02K

−0.4%

Lucera Erick

EVP, CHIEF FINANCIAL OFFICER

—

112,720

0.0734%

$342.35K

−3.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 14

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 7 Sep 2016